Who should not use it Its not the right choice for patients with: active cancer or a cancer history (stimulating cell growth signals can be harmful in these cases) active autoimmune conditions, where anything that affects the immune system carries additional risk pregnancy or breastfeeding significantly compromised liver or kidney function These arent minor caveats
And monitor your metabolic health comprehensively: a thorough comprehensive metabolic panel provides baseline liver, kidney, and glucose data that is essential context for anyone adding any new compound to their protocol
Phase II human trials of thymosin beta-4 (TB-500's parent molecule) have been conducted examining tissue repair rates, with studies reporting acceleration of repair in patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa wounds, though detailed results remain limited in peer-reviewed literature
Advertising and promotion following agreement of the Windsor Framework
Indeed, nNOS induction has been noted with a 6 day sleep deprivation protocol in mice (Hu et al., 1994
doi: 10.3390/ijms22094861 32 ChatawayJ.WilliamsT.LiV.MarrieR